Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Study examines association between neighborhood disadvantage and DNA methylation in brain tissue

Study examines association between neighborhood disadvantage and DNA methylation in brain tissue

Ensemble deep learning models enhance early diagnosis of Alzheimer's disease using neuroimaging data

Ensemble deep learning models enhance early diagnosis of Alzheimer's disease using neuroimaging data

Superagers' brains resist age-related decline, study finds

Superagers' brains resist age-related decline, study finds

Youth-onset diabetes linked to higher Alzheimer's risk

Youth-onset diabetes linked to higher Alzheimer's risk

FAU researchers receive grants to tackle Alzheimer's disease

FAU researchers receive grants to tackle Alzheimer's disease

Mathematical microscope sheds light on efficient memory formation even during sleep

Mathematical microscope sheds light on efficient memory formation even during sleep

APOE4 gene linked to early onset Alzheimer's, target for therapeutic intervention

APOE4 gene linked to early onset Alzheimer's, target for therapeutic intervention

Study identifies APOE4 homozygotes as high-risk group for Alzheimer's disease

Study identifies APOE4 homozygotes as high-risk group for Alzheimer's disease

Global research offers insights about health burden disparities between genders

Global research offers insights about health burden disparities between genders

Rapamycin shows promise in slowing Alzheimer's disease progression linked to seizures

Rapamycin shows promise in slowing Alzheimer's disease progression linked to seizures

Genes affecting worm behavior found to be relevant to neurological disease in humans

Genes affecting worm behavior found to be relevant to neurological disease in humans

Generation Z urged to prioritize gum health

Generation Z urged to prioritize gum health

Benefits and challenges of integrating nursing home residents into clinical trials

Benefits and challenges of integrating nursing home residents into clinical trials

New study reveals potential cellular mechanism behind cognitive decline in Alzheimer's

New study reveals potential cellular mechanism behind cognitive decline in Alzheimer's

New imaging technique provides a much closer look at fibril assemblies

New imaging technique provides a much closer look at fibril assemblies

Researchers uncover mechanism behind mitochondrial dysfunction in Alzheimer's

Researchers uncover mechanism behind mitochondrial dysfunction in Alzheimer's

Better cardiovascular health among middle-aged Black women linked to less decline in cognition

Better cardiovascular health among middle-aged Black women linked to less decline in cognition

Neurons re-entering cell cycle succumb to senescence in neurodegenerative diseases

Neurons re-entering cell cycle succumb to senescence in neurodegenerative diseases

$4.8 million grant supports research on TDP-43 misfolding in neurodegenerative diseases

$4.8 million grant supports research on TDP-43 misfolding in neurodegenerative diseases

Bursts of beta rhythms control cognition in the brain

Bursts of beta rhythms control cognition in the brain

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.